XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Jun. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Product Information [Line Items]            
Federal insured amount $ 250,000     $ 250,000    
Cash balance, amount 13,343,000     13,343,000    
Cash equivalent balance, amount 13,093,000     $ 13,093,000    
Potentially dilutive equity instruments that are convertible into common stock       7,992,829 7,881,160  
Goodwill and intangible asset impairment $ 631,064 $ 631,064  
Contract with customer liability current 474,888     474,888   $ 4,338,570
Revenue recognized 12,461 125,731   3,911,083 2,318,935  
Revenue remaining performance obligation 548,000     $ 548,000    
Product warranty description       The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue    
Accrued warranty reserve amount $ 194,031     $ 194,031   $ 180,457
Stock price volatility       152.23%    
Expected Term       10 years    
Risk-free interest rate       3.48%    
Accrued Incentive   $ 23,187   $ 0 $ 69,561  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage 29.00% 53.00%   38.00% 28.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage 19.00% 24.00%   20.00% 25.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage 16.00%     12.00% 13.00%  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Four [Member]            
Product Information [Line Items]            
Concentration risk percentage 12.00%          
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage       78.00%   57.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage       12.00%   43.00%
2023 [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation $ 195,000     $ 195,000    
2023 [Member] | Booked Sales Orders From Three Customers [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation 353,000     $ 353,000    
Director And Staff [Member]            
Product Information [Line Items]            
Potentially dilutive equity instruments that are convertible into common stock       369,057 257,388  
One Customer [Member]            
Product Information [Line Items]            
Revenue remaining performance obligation $ 65,000     $ 65,000    
Series B Preferred Stock [Member]            
Product Information [Line Items]            
Potentially dilutive equity instruments that are convertible into common stock       7,623,772 7,623,772